☆ 4.5 Review

Causes and risk profiles of mortality among individuals with nonalcoholic fatty liver disease

CLINICAL AND MOLECULAR HEPATOLOGY (2023)

Related references

Note: Only part of the references are listed.

Article Gastroenterology & Hepatology

Gallstone Disease and Its Association With Nonalcoholic Fatty Liver Disease, All-Cause and Cause-Specific Mortality

Peter Konyn et al.

Summary: Gallstone disease is an independent risk factor for NAFLD but is not associated with all-cause mortality in individuals with NAFLD. Screening for gallstone disease may help stratify the risk of all-cause mortality related to gallstone disease.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2023)

Add to Collection

Article Gastroenterology & Hepatology

NAFLD-related gene polymorphisms and all-cause and cause-specific mortality in an Asian population: the Shanghai Changfeng Study

Mingfeng Xia et al.

Summary: The PNPLA3 rs738409 C>G variant and its combination with the TM6SF2 rs58542926 C>T and MBOAT7 rs641738 C>T variants increase liver-specific mortality but reduce cardiovascular mortality in overweight/obese Chinese individuals. The reduced serum VLDL1 concentration is responsible for the increased liver-specific mortality associated with NAFLD risk alleles.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2022)

Add to Collection

Article Gastroenterology & Hepatology

Non-alcoholic fatty liver disease and increased risk of incident extrahepatic cancers: a meta-analysis of observational cohort studies

Alessandro Mantovani et al.

Summary: This meta-analysis found that NAFLD was significantly associated with an increased risk of developing gastrointestinal cancers (esophagus, stomach, pancreas, or colorectal cancers) by nearly 1.5-fold to 2-fold, as well as an increased risk of developing lung, breast, gynecological, or urinary system cancers by approximately 1.2-fold to 1.5-fold. These risks were independent of age, sex, smoking, obesity, diabetes, or other potential confounders.

GUT (2022)

Add to Collection

Letter Health Care Sciences & Services

Prevalence of Nonalcoholic Fatty Liver Disease and Hepatic Fibrosis Among US Adults with Prediabetes and Diabetes, NHANES 2017-2018

Donghee Kim et al.

JOURNAL OF GENERAL INTERNAL MEDICINE (2022)

Add to Collection

Article Gastroenterology & Hepatology

Physical Activity Is Associated With Nonalcoholic Fatty Liver Disease and Significant Fibrosis Measured by FibroScan

Donghee Kim et al.

Summary: Meeting the guidelines for leisure-time physical activity has beneficial effects on nonalcoholic fatty liver disease, and exceeding the recommended amount of activity reduces the risk for significant fibrosis or cirrhosis.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

Add to Collection

Editorial Material Gastroenterology & Hepatology

Nonalcoholic fatty liver disease in early life and all-cause and cause-specific mortality

Donghee Kim et al.

HEPATOBILIARY SURGERY AND NUTRITION (2022)

Add to Collection

Review Gastroenterology & Hepatology

Nonalcoholic fatty liver disease versus metabolic-associated fatty liver disease: Prevalence, outcomes and implications of a change in name

Cheng Han Ng et al.

Summary: Nonalcoholic fatty liver disease (NAFLD) affects a large percentage of the adult population worldwide. Recent studies suggest that renaming it to metabolic-associated fatty liver disease (MAFLD) may better reflect its underlying pathophysiology and highlight the higher prevalence of metabolic comorbidities and mortality rates compared to NAFLD.

CLINICAL AND MOLECULAR HEPATOLOGY (2022)

Add to Collection

Review Gastroenterology & Hepatology

Impact of diabetes, obesity, and dyslipidemia on the risk of hepatocellular carcinoma in patients with chronic liver diseases

Hwang Sik Shin et al.

Summary: This review comprehensively summarizes the relationship between metabolic factors such as diabetes mellitus, obesity, and blood lipids and the risk of hepatocellular carcinoma (HCC) in patients with chronic liver diseases. Diabetes consistently increases the risk of HCC in patients with chronic liver disease, while obesity may also increase the risk. In terms of blood lipids, total cholesterol, low-density lipoprotein cholesterol, and triglyceride have strong inverse associations with HCC in individuals with chronic liver diseases.

CLINICAL AND MOLECULAR HEPATOLOGY (2022)

Add to Collection

Review Cell Biology

Non-alcoholic fatty liver disease-related fibrosis and sarcopenia: An altered liver-muscle crosstalk leading to increased mortality risk

Mohammad Shafi Kuchay et al.

Summary: In the last few decades, sarcopenia and non-alcoholic fatty liver disease (NAFLD) have become major global health concerns, with increasing prevalence. The combination of sarcopenia and NAFLD-related fibrosis increases the risk of all-cause and cardiac-specific mortality. The two conditions share common patho-physiological pathways, including insulin resistance, chronic inflammation, hyperammonemia, and alterations in hormonal signaling. The gut microbiome may also play a role in this relationship.

AGEING RESEARCH REVIEWS (2022)

Add to Collection

Letter Gastroenterology & Hepatology

Longitudinal Change in Thyroid-Stimulating Hormone and Risk of Nonalcoholic Fatty Liver Disease

Goh Eun Chung et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)

Add to Collection

Letter Gastroenterology & Hepatology

PNPLA3 Gene Polymorphism and Liver- and Extrahepatic Cancer-Related Mortality in the United States

Karn Wijarnpreecha et al.

Summary: The PNPLA3 rs738409 G allele is associated with NAFLD, hepatocellular carcinoma, and overall or cardiovascular mortality. Studies show that women carrying the G allele without hepatic steatosis have a 60% lower risk for cancer-related mortality.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)

Add to Collection

Letter Gastroenterology & Hepatology

Prevalence of Fatty Liver Disease and Fibrosis Detected by Transient Elastography in Adults in the United States, 2017-2018

Donghee Kim et al.

Summary: Accurate assessment and estimation of fatty liver disease and hepatic fibrosis are crucial in clinical practice. Studies have shown that the application of transient elastography and controlled attenuation parameter has improved the measurement accuracy of fatty liver disease and hepatic fibrosis.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)

Add to Collection

Article Gastroenterology & Hepatology

Physical Activity, Measured Objectively, Is Associated With Lower Mortality in Patients With Nonalcoholic Fatty Liver Disease

Donghee Kim et al.

Summary: Increasing the duration of total PA and moderate to vigorous PA is associated with lower all-cause and cardiovascular mortality in individuals with NAFLD, while longer duration of sedentary behavior does not affect mortality risk.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)

Add to Collection

Review Cardiac & Cardiovascular Systems

NAFLD and cardiovascular diseases: a clinical review

Philipp Kasper et al.

Summary: NAFLD, the most common chronic liver disease in Western countries, is closely associated with metabolic comorbidities and poses a significant risk for cardiovascular disease development, especially in patients with progressive forms of the disease and those with concurrent type 2 diabetes.

CLINICAL RESEARCH IN CARDIOLOGY (2021)

Add to Collection

Article Gastroenterology & Hepatology

Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort

Tracey G. Simon et al.

Summary: Population-based data in Sweden showed that all histological stages of NAFLD were linked with significantly increased overall mortality, and the risk escalated progressively with worsening histology. Excess mortality was mainly attributed to extrahepatic cancer and cirrhosis, while cardiovascular disease and HCC made modest contributions.

GUT (2021)

Add to Collection

Review Gastroenterology & Hepatology

Recent Epidemiology of Nonalcoholic Fatty Liver Disease

Soumya Murag et al.

Summary: The rising prevalence of nonalcoholic fatty liver disease (NAFLD) due to the obesity epidemic and metabolic syndrome has led to increased healthcare costs. Diagnostic challenges include identifying NAFLD patients at higher risk of progressing to end-stage liver disease.

GUT AND LIVER (2021)

Add to Collection

Article Gastroenterology & Hepatology

KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease

Seong Hee Kang et al.

CLINICAL AND MOLECULAR HEPATOLOGY (2021)

Add to Collection

Article Gastroenterology & Hepatology

AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achieve Weight Loss in the Management of Nonalcoholic Fatty Liver Disease: Expert Review

Zobair M. Younossi et al.

Summary: NAFLD is a leading cause of chronic liver disease globally, affecting over 25% of the population. Lifestyle modification for weight loss is the primary intervention for patients with NAFLD. Evidence-based interventions and best practice advice are provided for clinical management of NAFLD.

GASTROENTEROLOGY (2021)

Add to Collection

Article Gastroenterology & Hepatology

Sarcopenia in nonalcoholic fatty liver disease and all-cause and cause-specific mortality in the United States

Donghee Kim et al.

Summary: In the USA, sarcopenia is associated with increased all-cause and cause-specific mortality in individuals with NAFLD, indicating a higher mortality risk for those with both conditions.

LIVER INTERNATIONAL (2021)

Add to Collection

Article Gastroenterology & Hepatology

Current epidemiology in hepatocellular carcinoma

Peter Konyn et al.

Summary: This review discusses the risk factors, global trends, and high incidence rates of HCC in Asia and Africa. Interventions to minimize the global burden of HCC include reducing common risk factors, treating underlying causes effectively, and implementing comprehensive screening programs for HCC. Healthcare inequity is identified as a crucial area for improvement in addressing disparities in HCC incidence and mortality among racial and ethnic minorities in multiethnic countries.

EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2021)

Add to Collection

Article Medicine, General & Internal

Trends in Prevalence of Diabetes and Control of Risk Factors in Diabetes Among US Adults, 1999-2018

Li Wang et al.

Summary: The study based on NHANES data from US adults reveals a significant increase in the prevalence of diabetes between 1999-2000 and 2017-2018. Only around 21% of adults with diagnosed diabetes achieved all three risk factor control goals in 2015-2018.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Add to Collection

Article Gastroenterology & Hepatology

Epidemiology and risk-stratification of NAFLD-associated HCC

George N. Ioannou

Summary: NAFLD is projected to be the leading cause of hepatocellular carcinoma and is associated with risk factors such as obesity, diabetes, Hispanic ethnicity, and genetic polymorphisms. Lipotoxicity and oxidative DNA damage may lead to hepatocarcinogenesis, especially in the absence of cirrhosis. Validated models to identify high-risk patients for hepatocellular carcinoma in NAFLD are currently unavailable.

JOURNAL OF HEPATOLOGY (2021)

Add to Collection

Article Gastroenterology & Hepatology

Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States

Donghee Kim et al.

Summary: This study demonstrated that metabolic dysfunction-associated fatty liver disease (MAFLD) was associated with an increased risk of all-cause mortality in US adults, while non-alcoholic fatty liver disease (NAFLD) showed no association with all-cause mortality after adjusting for metabolic risk factors. Individuals who met the criteria for MAFLD but not NAFLD had a higher risk of all-cause mortality.

JOURNAL OF HEPATOLOGY (2021)

Add to Collection

Article Geriatrics & Gerontology

Non-alcoholic fatty liver disease and sarcopenia additively increase mortality: a Korean nationwide survey

Joon Ho Moon et al.

Summary: This study found that the coexistence of NAFLD and sarcopenia significantly increased the risk of mortality, especially in the presence of advanced fibrosis in NAFLD. Additionally, the additive effect of NAFLD and sarcopenia on mortality risk suggests the importance of risk stratification for predicting mortality in individuals with metabolic derangements.

JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2021)

Add to Collection

Letter Gastroenterology & Hepatology

Increasing Mortality Among Patients With Diabetes and Chronic Liver Disease From 2007 to 2017

Donghee Kim et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)

Add to Collection

Review Gastroenterology & Hepatology

Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease

Andrew A. Li et al.

GUT AND LIVER (2020)

Add to Collection

Article Gastroenterology & Hepatology

Attributable Fractions of Nonalcoholic Fatty Liver Disease for Mortality in the United States: Results From the Third National Health and Nutrition Examination Survey With 27 Years of Follow-up

Christian S. Alvarez et al.

HEPATOLOGY (2020)

Add to Collection

Article Gastroenterology & Hepatology

Association Between Fibrosis Stage and Outcomes of Patients with Non-Alcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis

Rod S. Taylor et al.

GASTROENTEROLOGY (2020)

Add to Collection

Article Gastroenterology & Hepatology

Metabolic Inflammation-A Role for Hepatic Inflammatory Pathways as Drivers of Comorbidities in Nonalcoholic Fatty Liver Disease?

Nadine Gehrke et al.

GASTROENTEROLOGY (2020)

Add to Collection

Article Gastroenterology & Hepatology

Inadequate Physical Activity and Sedentary Behavior Are Independent Predictors of Nonalcoholic Fatty Liver Disease

Donghee Kim et al.

HEPATOLOGY (2020)

Add to Collection

Article Gastroenterology & Hepatology

Diet quality and its association with nonalcoholic fatty liver disease and all-cause and cause-specific mortality

Eric R. Yoo et al.

LIVER INTERNATIONAL (2020)

Add to Collection

Editorial Material Gastroenterology & Hepatology

Decline in Annual Mortality of Hepatitis C Virus-Related Hepatocellular Carcinoma in the United States, From 2009 to 2018

Donghee Kim et al.

GASTROENTEROLOGY (2020)

Add to Collection

Review Medicine, General & Internal

Nonalcoholic Steatohepatitis: A Review

Adam C. Sheka et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Add to Collection

Article Gastroenterology & Hepatology

PNPLA3 gene polymorphism and overall and cardiovascular mortality in the United States

Karn Wijarnpreecha et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2020)

Add to Collection

Article Gastroenterology & Hepatology

Low Thyroid Function in Nonalcoholic Fatty Liver Disease Is an Independent Predictor of All-Cause and Cardiovascular Mortality

Donghee Kim et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2020)

Add to Collection

Article Gastroenterology & Hepatology

A common variant in PNPLA3 is associated with age at diagnosis of NAFLD in patients from a multi-ethnic biobank

Ryan W. Walker et al.

JOURNAL OF HEPATOLOGY (2020)

Add to Collection

Article Medicine, General & Internal

Tumor Incidence in Patients with Non-Alcoholic Fatty Liver Disease

Yvonne Huber et al.

DEUTSCHES ARZTEBLATT INTERNATIONAL (2020)

Add to Collection

Article Gastroenterology & Hepatology

Contribution of sarcopenia and physical inactivity to mortality in people with non-alcoholic fatty liver disease

Pegah Golabi et al.

JHEP REPORTS (2020)

Add to Collection

Article Gastroenterology & Hepatology

Trends in the prevalence of chronic liver disease in the Korean adult population, 1998-2017

Seung Ha Park et al.

CLINICAL AND MOLECULAR HEPATOLOGY (2020)

Add to Collection

Article Gastroenterology & Hepatology

Changing Trends in Etiology-Based and Ethnicity-Based Annual Mortality Rates of Cirrhosis and Hepatocellular Carcinoma in the United States

Donghee Kim et al.

HEPATOLOGY (2019)

Add to Collection

Article Gastroenterology & Hepatology

Race/ethnicity-based temporal changes in prevalence of NAFLD-related advanced fibrosis in the United States, 2005-2016

Donghee Kim et al.

HEPATOLOGY INTERNATIONAL (2019)

Add to Collection

Editorial Material Gastroenterology & Hepatology

Genetic Factors and Continental Ancestry Account for Some Disparities in Nonalcoholic Fatty Liver Disease Among Hispanic Subgroups

Eric R. Yoo et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)

Add to Collection

Article Endocrinology & Metabolism

Trends in overall, cardiovascular and cancer-related mortality among individuals with diabetes reported on death certificates in the United States between 2007 and 2017

Donghee Kim et al.

DIABETOLOGIA (2019)

Add to Collection

Article Gastroenterology & Hepatology

Trends in Mortality From Extrahepatic Complications in Patients With Chronic Liver Disease, From 2007 Through 2017

Donghee Kim et al.

GASTROENTEROLOGY (2019)

Add to Collection

Review Gastroenterology & Hepatology

The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis

Zobair M. Younossi et al.

JOURNAL OF HEPATOLOGY (2019)

Add to Collection

Article Gastroenterology & Hepatology

The risk of incident extrahepatic cancers is higher in non-alcoholic fatty liver disease than obesity - A longitudinal cohort study

Alina M. Allen et al.

JOURNAL OF HEPATOLOGY (2019)

Add to Collection

Letter Gastroenterology & Hepatology

Low-Normal Thyroid Function Is Associated With Advanced Fibrosis Among Adults in the United States

Donghee Kim et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)

Add to Collection

Article Gastroenterology & Hepatology

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

Naga Chalasani et al.

HEPATOLOGY (2018)

Add to Collection

Article Gastroenterology & Hepatology

Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease

Chris Estes et al.

HEPATOLOGY (2018)

Add to Collection

Article Gastroenterology & Hepatology

Subclinical Hypothyroidism and Low-Normal Thyroid Function Are Associated With Nonalcoholic Steatohepatitis and Fibrosis

Donghee Kim et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)

Add to Collection

Article Gastroenterology & Hepatology

Nonalcoholic Fatty Liver Disease and Metabolic Syndrome

Donghee Kim et al.

CLINICS IN LIVER DISEASE (2018)

Add to Collection

Article Gastroenterology & Hepatology

Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study

Eduardo Vilar-Gomez et al.

GASTROENTEROLOGY (2018)

Add to Collection

Letter Gastroenterology & Hepatology

The PNPLA3 SNP rs738409:G allele is associated with increased liver disease-associated mortality but reduced overall mortality in a population-based cohort

Peter J. Meffert et al.

JOURNAL OF HEPATOLOGY (2018)

Add to Collection

Article Gastroenterology & Hepatology

Association between non-alcoholic fatty liver disease and cancer incidence rate

Gi-Ae Kim et al.

JOURNAL OF HEPATOLOGY (2018)

Add to Collection

Article Gastroenterology & Hepatology

Changing Trends in Etiology-Based Annual Mortality From Chronic Liver Disease, From 2007 Through 2016

Donghee Kim et al.

GASTROENTEROLOGY (2018)

Add to Collection

Review Medicine, General & Internal

The Physical Activity Guidelines for Americans

Katrina L. Piercy et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)

Add to Collection

Letter Gastroenterology & Hepatology

PNPLA3, TM6SF2, and MBOAT7 Genotypes and Coronary Artery Disease

Nynke Simons et al.

GASTROENTEROLOGY (2017)

Add to Collection

Review Gastroenterology & Hepatology

Increased Risk of Mortality by Fibrosis Stage in Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis

Parambir S. Dulai et al.

HEPATOLOGY (2017)

Add to Collection

Article Gastroenterology & Hepatology

Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis

Bo Kyung Koo et al.

JOURNAL OF HEPATOLOGY (2017)

Add to Collection

Article Gastroenterology & Hepatology

Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes

Zobair M. Younossi et al.

HEPATOLOGY (2016)

Add to Collection

Article Gastroenterology & Hepatology

Association of Nonalcoholic Fatty Liver Disease (NAFLD) with Hepatocellular Carcinoma (HCC) in the United States From 2004 to 2009

Zobair M. Younossi et al.

HEPATOLOGY (2015)

Add to Collection

Article Gastroenterology & Hepatology

Sarcopaenia is associated with NAFLD independently of obesity and insulin resistance: Nationwide surveys (KNHANES 2008-2011)

Yong-ho Lee et al.

JOURNAL OF HEPATOLOGY (2015)

Add to Collection

Article Gastroenterology & Hepatology

Relationship Between Sarcopenia and Nonalcoholic Fatty Liver Disease: The Korean Sarcopenic Obesity Study

Ho Cheol Hong et al.

HEPATOLOGY (2014)

Add to Collection

Article Gastroenterology & Hepatology

Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States

Donghee Kim et al.

HEPATOLOGY (2013)

Add to Collection

Article Gastroenterology & Hepatology

Non-alcoholic fatty liver disease across the spectrum of hypothyroidism

Goh Eun Chung et al.

JOURNAL OF HEPATOLOGY (2012)

Add to Collection

Article Gastroenterology & Hepatology

Physical Activity Recommendations, Exercise Intensity, and Histological Severity of Nonalcoholic Fatty Liver Disease

Kristin D. Kistler et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)

Add to Collection

Article Gastroenterology & Hepatology

Randomized Comparison of Reduced Fat and Reduced Carbohydrate Hypocaloric Diets on Intrahepatic Fat in Overweight and Obese Human Subjects

Sven Haufe et al.

HEPATOLOGY (2011)

Add to Collection

Article Gastroenterology & Hepatology

Meta-Analysis of the Influence of I148M Variant of Patatin-Like Phospholipase Domain Containing 3 Gene (PNPLA3) on the Susceptibility and Histological Severity of Nonalcoholic Fatty Liver Disease

Silvia Sookoian et al.

HEPATOLOGY (2011)

Add to Collection

Article Gastroenterology & Hepatology

Elevated Serum Alanine Aminotransferase and γ-Glutamyltransferase and Mortality in the United States Population

Constance E. Ruhl et al.

GASTROENTEROLOGY (2009)

Add to Collection

Article Gastroenterology & Hepatology

The natural history of nonalcoholic fatty liver disease: A population-based cohort study

LA Adams et al.

GASTROENTEROLOGY (2005)

Add to Collection

Article Gastroenterology & Hepatology

Long term prognosis of fatty liver: risk of chronic liver disease and death

S Dam-Larsen et al.

GUT (2004)

Add to Collection

© Peeref 2019-2024. All rights reserved.